Timing of testing and treatment for asymptomatic diseases

DOI10.1016/J.MBS.2010.03.007zbMATH Open1193.92060OpenAlexW1965502082WikidataQ44568605 ScholiaQ44568605MaRDI QIDQ985247FDOQ985247

Authors: Eser Kırkızlar, Daniel M. Faissol, Paul M. Griffin, Julie Swann 

Publication date: 20 July 2010

Published in: Mathematical Biosciences (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.mbs.2010.03.007

Recommendations

• On Optimal Screening Ages
• Planning for HIV screening, testing, and care at the veterans health administration
• Timing medical examinations via intensity functions
• A Markov decision process in medical treatment of Hepatitis C
• Mass Screening Models for Contagious Diseases with No Latent Period

zbMATH Keywords

Markov decision processeshepatitis Cdisease modelingasymptomatic diseasesdisease screening and intervention

Mathematics Subject Classification ID

Medical applications (general) (92C50) Markov and semi-Markov decision processes (90C40)

Cites Work

• Title not available (Why is that?)
• The Optimal Control of Partially Observable Markov Processes over a Finite Horizon
• Optimal scheduling of examinations for the early detection of disease
• Optimal Scheduling of Fallible Inspections
• On Optimal Screening Ages
• A Two-State Partially Observable Markov Decision Process with Uniformly Distributed Observations
• Improved inspection schemes for deteriorating equipment
• Title not available (Why is that?)
• Mass Screening Models for Contagious Diseases with No Latent Period
• Optimal Scheduling of Inspections: A Delayed Markov Model with False Positives and Negatives
• Optimal Stopping in a Partially Observable Markov Process with Costly Information
• Inspection policies and processes for deteriorating systems subject to catastrophic failure
• Title not available (Why is that?)
• Title not available (Why is that?)
• Optimal Inspection and Repair of a Production Process Subject to Deterioration
• Timing medical examinations via intensity functions
• Early detection of disease and scheduling of screening examinations
• Estimating distribution of the age of onset of detectable asymptomatic cancer

Cited In (5)

• Bias in Markov models of disease
• Optimal M-Switch Surveillance Policies for Liver Cancer in a Hepatitis C–Infected Population
• Cost-effective control of chronic viral diseases: finding the optimal level of screening and contact tracing
• A Markov decision process in medical treatment of Hepatitis C
• Optimal timing to initiate medical treatment for a disease evolving as a semi-Markov process

This page was built for publication: Timing of testing and treatment for asymptomatic diseases

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q985247)